Global Novel Drug Delivery Systems Market Insights and Forecast to 2028

Report ID: 1123048 | Published Date: Jan 2025 | No. of Page: 128 | Base Year: 2024 | Rating: 3.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Novel Drug Delivery Systems Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Liposomes
        1.2.3 PEGylated Proteins & Polypeptides
        1.2.4 Polymer Nanoparticle
        1.2.5 Protein–drug Conjugates
        1.2.6 Others
    1.3 Market by Application
        1.3.1 Global Novel Drug Delivery Systems Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospitals & Clinic
        1.3.3 Cancer Treatment Centers
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Novel Drug Delivery Systems Market Perspective (2017-2028)
    2.2 Novel Drug Delivery Systems Growth Trends by Region
        2.2.1 Novel Drug Delivery Systems Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Novel Drug Delivery Systems Historic Market Size by Region (2017-2022)
        2.2.3 Novel Drug Delivery Systems Forecasted Market Size by Region (2023-2028)
    2.3 Novel Drug Delivery Systems Market Dynamics
        2.3.1 Novel Drug Delivery Systems Industry Trends
        2.3.2 Novel Drug Delivery Systems Market Drivers
        2.3.3 Novel Drug Delivery Systems Market Challenges
        2.3.4 Novel Drug Delivery Systems Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Novel Drug Delivery Systems Players by Revenue
        3.1.1 Global Top Novel Drug Delivery Systems Players by Revenue (2017-2022)
        3.1.2 Global Novel Drug Delivery Systems Revenue Market Share by Players (2017-2022)
    3.2 Global Novel Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Novel Drug Delivery Systems Revenue
    3.4 Global Novel Drug Delivery Systems Market Concentration Ratio
        3.4.1 Global Novel Drug Delivery Systems Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Novel Drug Delivery Systems Revenue in 2021
    3.5 Novel Drug Delivery Systems Key Players Head office and Area Served
    3.6 Key Players Novel Drug Delivery Systems Product Solution and Service
    3.7 Date of Enter into Novel Drug Delivery Systems Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Novel Drug Delivery Systems Breakdown Data by Type
    4.1 Global Novel Drug Delivery Systems Historic Market Size by Type (2017-2022)
    4.2 Global Novel Drug Delivery Systems Forecasted Market Size by Type (2023-2028)
5 Novel Drug Delivery Systems Breakdown Data by Application
    5.1 Global Novel Drug Delivery Systems Historic Market Size by Application (2017-2022)
    5.2 Global Novel Drug Delivery Systems Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Novel Drug Delivery Systems Market Size (2017-2028)
    6.2 North America Novel Drug Delivery Systems Market Size by Type
        6.2.1 North America Novel Drug Delivery Systems Market Size by Type (2017-2022)
        6.2.2 North America Novel Drug Delivery Systems Market Size by Type (2023-2028)
        6.2.3 North America Novel Drug Delivery Systems Market Share by Type (2017-2028)
    6.3 North America Novel Drug Delivery Systems Market Size by Application
        6.3.1 North America Novel Drug Delivery Systems Market Size by Application (2017-2022)
        6.3.2 North America Novel Drug Delivery Systems Market Size by Application (2023-2028)
        6.3.3 North America Novel Drug Delivery Systems Market Share by Application (2017-2028)
    6.4 North America Novel Drug Delivery Systems Market Size by Country
        6.4.1 North America Novel Drug Delivery Systems Market Size by Country (2017-2022)
        6.4.2 North America Novel Drug Delivery Systems Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Novel Drug Delivery Systems Market Size (2017-2028)
    7.2 Europe Novel Drug Delivery Systems Market Size by Type
        7.2.1 Europe Novel Drug Delivery Systems Market Size by Type (2017-2022)
        7.2.2 Europe Novel Drug Delivery Systems Market Size by Type (2023-2028)
        7.2.3 Europe Novel Drug Delivery Systems Market Share by Type (2017-2028)
    7.3 Europe Novel Drug Delivery Systems Market Size by Application
        7.3.1 Europe Novel Drug Delivery Systems Market Size by Application (2017-2022)
        7.3.2 Europe Novel Drug Delivery Systems Market Size by Application (2023-2028)
        7.3.3 Europe Novel Drug Delivery Systems Market Share by Application (2017-2028)
    7.4 Europe Novel Drug Delivery Systems Market Size by Country
        7.4.1 Europe Novel Drug Delivery Systems Market Size by Country (2017-2022)
        7.4.2 Europe Novel Drug Delivery Systems Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Novel Drug Delivery Systems Market Size (2017-2028)
    8.2 Asia-Pacific Novel Drug Delivery Systems Market Size by Type
        8.2.1 Asia-Pacific Novel Drug Delivery Systems Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Novel Drug Delivery Systems Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Novel Drug Delivery Systems Market Share by Type (2017-2028)
    8.3 Asia-Pacific Novel Drug Delivery Systems Market Size by Application
        8.3.1 Asia-Pacific Novel Drug Delivery Systems Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Novel Drug Delivery Systems Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Novel Drug Delivery Systems Market Share by Application (2017-2028)
    8.4 Asia-Pacific Novel Drug Delivery Systems Market Size by Region
        8.4.1 Asia-Pacific Novel Drug Delivery Systems Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Novel Drug Delivery Systems Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Novel Drug Delivery Systems Market Size (2017-2028)
    9.2 Latin America Novel Drug Delivery Systems Market Size by Type
        9.2.1 Latin America Novel Drug Delivery Systems Market Size by Type (2017-2022)
        9.2.2 Latin America Novel Drug Delivery Systems Market Size by Type (2023-2028)
        9.2.3 Latin America Novel Drug Delivery Systems Market Share by Type (2017-2028)
    9.3 Latin America Novel Drug Delivery Systems Market Size by Application
        9.3.1 Latin America Novel Drug Delivery Systems Market Size by Application (2017-2022)
        9.3.2 Latin America Novel Drug Delivery Systems Market Size by Application (2023-2028)
        9.3.3 Latin America Novel Drug Delivery Systems Market Share by Application (2017-2028)
    9.4 Latin America Novel Drug Delivery Systems Market Size by Country
        9.4.1 Latin America Novel Drug Delivery Systems Market Size by Country (2017-2022)
        9.4.2 Latin America Novel Drug Delivery Systems Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Novel Drug Delivery Systems Market Size (2017-2028)
    10.2 Middle East & Africa Novel Drug Delivery Systems Market Size by Type
        10.2.1 Middle East & Africa Novel Drug Delivery Systems Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Novel Drug Delivery Systems Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Novel Drug Delivery Systems Market Share by Type (2017-2028)
    10.3 Middle East & Africa Novel Drug Delivery Systems Market Size by Application
        10.3.1 Middle East & Africa Novel Drug Delivery Systems Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Novel Drug Delivery Systems Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Novel Drug Delivery Systems Market Share by Application (2017-2028)
    10.4 Middle East & Africa Novel Drug Delivery Systems Market Size by Country
        10.4.1 Middle East & Africa Novel Drug Delivery Systems Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Novel Drug Delivery Systems Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Amgen
        11.1.1 Amgen Company Details
        11.1.2 Amgen Business Overview
        11.1.3 Amgen Novel Drug Delivery Systems Introduction
        11.1.4 Amgen Revenue in Novel Drug Delivery Systems Business (2017-2022)
        11.1.5 Amgen Recent Developments
    11.2 Teva
        11.2.1 Teva Company Details
        11.2.2 Teva Business Overview
        11.2.3 Teva Novel Drug Delivery Systems Introduction
        11.2.4 Teva Revenue in Novel Drug Delivery Systems Business (2017-2022)
        11.2.5 Teva Recent Developments
    11.3 Roche
        11.3.1 Roche Company Details
        11.3.2 Roche Business Overview
        11.3.3 Roche Novel Drug Delivery Systems Introduction
        11.3.4 Roche Revenue in Novel Drug Delivery Systems Business (2017-2022)
        11.3.5 Roche Recent Developments
    11.4 UCB (Union Chimique Belge)
        11.4.1 UCB (Union Chimique Belge) Company Details
        11.4.2 UCB (Union Chimique Belge) Business Overview
        11.4.3 UCB (Union Chimique Belge) Novel Drug Delivery Systems Introduction
        11.4.4 UCB (Union Chimique Belge) Revenue in Novel Drug Delivery Systems Business (2017-2022)
        11.4.5 UCB (Union Chimique Belge) Recent Developments
    11.5 Celgene
        11.5.1 Celgene Company Details
        11.5.2 Celgene Business Overview
        11.5.3 Celgene Novel Drug Delivery Systems Introduction
        11.5.4 Celgene Revenue in Novel Drug Delivery Systems Business (2017-2022)
        11.5.5 Celgene Recent Developments
    11.6 Merck
        11.6.1 Merck Company Details
        11.6.2 Merck Business Overview
        11.6.3 Merck Novel Drug Delivery Systems Introduction
        11.6.4 Merck Revenue in Novel Drug Delivery Systems Business (2017-2022)
        11.6.5 Merck Recent Developments
    11.7 Gilead Sciences
        11.7.1 Gilead Sciences Company Details
        11.7.2 Gilead Sciences Business Overview
        11.7.3 Gilead Sciences Novel Drug Delivery Systems Introduction
        11.7.4 Gilead Sciences Revenue in Novel Drug Delivery Systems Business (2017-2022)
        11.7.5 Gilead Sciences Recent Developments
    11.8 Sanofi
        11.8.1 Sanofi Company Details
        11.8.2 Sanofi Business Overview
        11.8.3 Sanofi Novel Drug Delivery Systems Introduction
        11.8.4 Sanofi Revenue in Novel Drug Delivery Systems Business (2017-2022)
        11.8.5 Sanofi Recent Developments
    11.9 Pfizer
        11.9.1 Pfizer Company Details
        11.9.2 Pfizer Business Overview
        11.9.3 Pfizer Novel Drug Delivery Systems Introduction
        11.9.4 Pfizer Revenue in Novel Drug Delivery Systems Business (2017-2022)
        11.9.5 Pfizer Recent Developments
    11.10 Takeda
        11.10.1 Takeda Company Details
        11.10.2 Takeda Business Overview
        11.10.3 Takeda Novel Drug Delivery Systems Introduction
        11.10.4 Takeda Revenue in Novel Drug Delivery Systems Business (2017-2022)
        11.10.5 Takeda Recent Developments
    11.11 Bausch&Lomb
        11.11.1 Bausch&Lomb Company Details
        11.11.2 Bausch&Lomb Business Overview
        11.11.3 Bausch&Lomb Novel Drug Delivery Systems Introduction
        11.11.4 Bausch&Lomb Revenue in Novel Drug Delivery Systems Business (2017-2022)
        11.11.5 Bausch&Lomb Recent Developments
    11.12 Samyang Biopharmaceuticals
        11.12.1 Samyang Biopharmaceuticals Company Details
        11.12.2 Samyang Biopharmaceuticals Business Overview
        11.12.3 Samyang Biopharmaceuticals Novel Drug Delivery Systems Introduction
        11.12.4 Samyang Biopharmaceuticals Revenue in Novel Drug Delivery Systems Business (2017-2022)
        11.12.5 Samyang Biopharmaceuticals Recent Developments
    11.13 Johnson & Johnson
        11.13.1 Johnson & Johnson Company Details
        11.13.2 Johnson & Johnson Business Overview
        11.13.3 Johnson & Johnson Novel Drug Delivery Systems Introduction
        11.13.4 Johnson & Johnson Revenue in Novel Drug Delivery Systems Business (2017-2022)
        11.13.5 Johnson & Johnson Recent Developments
    11.14 TOLMAR
        11.14.1 TOLMAR Company Details
        11.14.2 TOLMAR Business Overview
        11.14.3 TOLMAR Novel Drug Delivery Systems Introduction
        11.14.4 TOLMAR Revenue in Novel Drug Delivery Systems Business (2017-2022)
        11.14.5 TOLMAR Recent Developments
    11.15 Astellas
        11.15.1 Astellas Company Details
        11.15.2 Astellas Business Overview
        11.15.3 Astellas Novel Drug Delivery Systems Introduction
        11.15.4 Astellas Revenue in Novel Drug Delivery Systems Business (2017-2022)
        11.15.5 Astellas Recent Developments
    11.16 AMAG Pharmaceuticals
        11.16.1 AMAG Pharmaceuticals Company Details
        11.16.2 AMAG Pharmaceuticals Business Overview
        11.16.3 AMAG Pharmaceuticals Novel Drug Delivery Systems Introduction
        11.16.4 AMAG Pharmaceuticals Revenue in Novel Drug Delivery Systems Business (2017-2022)
        11.16.5 AMAG Pharmaceuticals Recent Developments
    11.17 AbbVie
        11.17.1 AbbVie Company Details
        11.17.2 AbbVie Business Overview
        11.17.3 AbbVie Novel Drug Delivery Systems Introduction
        11.17.4 AbbVie Revenue in Novel Drug Delivery Systems Business (2017-2022)
        11.17.5 AbbVie Recent Developments
    11.18 Dr Reddy
        11.18.1 Dr Reddy Company Details
        11.18.2 Dr Reddy Business Overview
        11.18.3 Dr Reddy Novel Drug Delivery Systems Introduction
        11.18.4 Dr Reddy Revenue in Novel Drug Delivery Systems Business (2017-2022)
        11.18.5 Dr Reddy Recent Developments
    11.19 AstraZeneca
        11.19.1 AstraZeneca Company Details
        11.19.2 AstraZeneca Business Overview
        11.19.3 AstraZeneca Novel Drug Delivery Systems Introduction
        11.19.4 AstraZeneca Revenue in Novel Drug Delivery Systems Business (2017-2022)
        11.19.5 AstraZeneca Recent Developments
    11.20 Aspen
        11.20.1 Aspen Company Details
        11.20.2 Aspen Business Overview
        11.20.3 Aspen Novel Drug Delivery Systems Introduction
        11.20.4 Aspen Revenue in Novel Drug Delivery Systems Business (2017-2022)
        11.20.5 Aspen Recent Developments
    11.21 Acrotech Biopharma
        11.21.1 Acrotech Biopharma Company Details
        11.21.2 Acrotech Biopharma Business Overview
        11.21.3 Acrotech Biopharma Novel Drug Delivery Systems Introduction
        11.21.4 Acrotech Biopharma Revenue in Novel Drug Delivery Systems Business (2017-2022)
        11.21.5 Acrotech Biopharma Recent Developments
    11.22 TWi Pharmaceuticals
        11.22.1 TWi Pharmaceuticals Company Details
        11.22.2 TWi Pharmaceuticals Business Overview
        11.22.3 TWi Pharmaceuticals Novel Drug Delivery Systems Introduction
        11.22.4 TWi Pharmaceuticals Revenue in Novel Drug Delivery Systems Business (2017-2022)
        11.22.5 TWi Pharmaceuticals Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
List of Tables
    Table 1. Global Novel Drug Delivery Systems Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Liposomes
    Table 3. Key Players of PEGylated Proteins & Polypeptides
    Table 4. Key Players of Polymer Nanoparticle
    Table 5. Key Players of Protein–drug Conjugates
    Table 6. Key Players of Others
    Table 7. Global Novel Drug Delivery Systems Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 8. Global Novel Drug Delivery Systems Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global Novel Drug Delivery Systems Market Size by Region (2017-2022) & (US$ Million)
    Table 10. Global Novel Drug Delivery Systems Market Share by Region (2017-2022)
    Table 11. Global Novel Drug Delivery Systems Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 12. Global Novel Drug Delivery Systems Market Share by Region (2023-2028)
    Table 13. Novel Drug Delivery Systems Market Trends
    Table 14. Novel Drug Delivery Systems Market Drivers
    Table 15. Novel Drug Delivery Systems Market Challenges
    Table 16. Novel Drug Delivery Systems Market Restraints
    Table 17. Global Novel Drug Delivery Systems Revenue by Players (2017-2022) & (US$ Million)
    Table 18. Global Novel Drug Delivery Systems Revenue Share by Players (2017-2022)
    Table 19. Global Top Novel Drug Delivery Systems by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Novel Drug Delivery Systems as of 2021)
    Table 20. Ranking of Global Top Novel Drug Delivery Systems Companies by Revenue (US$ Million) in 2021
    Table 21. Global 5 Largest Players Market Share by Novel Drug Delivery Systems Revenue (CR5 and HHI) & (2017-2022)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Novel Drug Delivery Systems Product Solution and Service
    Table 24. Date of Enter into Novel Drug Delivery Systems Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Novel Drug Delivery Systems Market Size by Type (2017-2022) & (US$ Million)
    Table 27. Global Novel Drug Delivery Systems Revenue Market Share by Type (2017-2022)
    Table 28. Global Novel Drug Delivery Systems Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 29. Global Novel Drug Delivery Systems Revenue Market Share by Type (2023-2028)
    Table 30. Global Novel Drug Delivery Systems Market Size by Application (2017-2022) & (US$ Million)
    Table 31. Global Novel Drug Delivery Systems Revenue Share by Application (2017-2022)
    Table 32. Global Novel Drug Delivery Systems Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 33. Global Novel Drug Delivery Systems Revenue Share by Application (2023-2028)
    Table 34. North America Novel Drug Delivery Systems Market Size by Type (2017-2022) & (US$ Million)
    Table 35. North America Novel Drug Delivery Systems Market Size by Type (2023-2028) & (US$ Million)
    Table 36. North America Novel Drug Delivery Systems Market Size by Application (2017-2022) & (US$ Million)
    Table 37. North America Novel Drug Delivery Systems Market Size by Application (2023-2028) & (US$ Million)
    Table 38. North America Novel Drug Delivery Systems Market Size by Country (2017-2022) & (US$ Million)
    Table 39. North America Novel Drug Delivery Systems Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Europe Novel Drug Delivery Systems Market Size by Type (2017-2022) & (US$ Million)
    Table 41. Europe Novel Drug Delivery Systems Market Size by Type (2023-2028) & (US$ Million)
    Table 42. Europe Novel Drug Delivery Systems Market Size by Application (2017-2022) & (US$ Million)
    Table 43. Europe Novel Drug Delivery Systems Market Size by Application (2023-2028) & (US$ Million)
    Table 44. Europe Novel Drug Delivery Systems Market Size by Country (2017-2022) & (US$ Million)
    Table 45. Europe Novel Drug Delivery Systems Market Size by Country (2023-2028) & (US$ Million)
    Table 46. Asia Pacific Novel Drug Delivery Systems Market Size by Type (2017-2022) & (US$ Million)
    Table 47. Asia Pacific Novel Drug Delivery Systems Market Size by Type (2023-2028) & (US$ Million)
    Table 48. Asia Pacific Novel Drug Delivery Systems Market Size by Application (2017-2022) & (US$ Million)
    Table 49. Asia Pacific Novel Drug Delivery Systems Market Size by Application (2023-2028) & (US$ Million)
    Table 50. Asia Pacific Novel Drug Delivery Systems Market Size by Region (2017-2022) & (US$ Million)
    Table 51. Asia Pacific Novel Drug Delivery Systems Market Size by Region (2023-2028) & (US$ Million)
    Table 52. Latin America Novel Drug Delivery Systems Market Size by Type (2017-2022) & (US$ Million)
    Table 53. Latin America Novel Drug Delivery Systems Market Size by Type (2023-2028) & (US$ Million)
    Table 54. Latin America Novel Drug Delivery Systems Market Size by Application (2017-2022) & (US$ Million)
    Table 55. Latin America Novel Drug Delivery Systems Market Size by Application (2023-2028) & (US$ Million)
    Table 56. Latin America Novel Drug Delivery Systems Market Size by Country (2017-2022) & (US$ Million)
    Table 57. Latin America Novel Drug Delivery Systems Market Size by Country (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa Novel Drug Delivery Systems Market Size by Type (2017-2022) & (US$ Million)
    Table 59. Middle East and Africa Novel Drug Delivery Systems Market Size by Type (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa Novel Drug Delivery Systems Market Size by Application (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Novel Drug Delivery Systems Market Size by Application (2023-2028) & (US$ Million)
    Table 62. Middle East and Africa Novel Drug Delivery Systems Market Size by Country (2017-2022) & (US$ Million)
    Table 63. Middle East and Africa Novel Drug Delivery Systems Market Size by Country (2023-2028) & (US$ Million)
    Table 64. Amgen Company Details
    Table 65. Amgen Business Overview
    Table 66. Amgen Novel Drug Delivery Systems Product
    Table 67. Amgen Revenue in Novel Drug Delivery Systems Business (2017-2022) & (US$ Million)
    Table 68. Amgen Recent Developments
    Table 69. Teva Company Details
    Table 70. Teva Business Overview
    Table 71. Teva Novel Drug Delivery Systems Product
    Table 72. Teva Revenue in Novel Drug Delivery Systems Business (2017-2022) & (US$ Million)
    Table 73. Teva Recent Developments
    Table 74. Roche Company Details
    Table 75. Roche Business Overview
    Table 76. Roche Novel Drug Delivery Systems Product
    Table 77. Roche Revenue in Novel Drug Delivery Systems Business (2017-2022) & (US$ Million)
    Table 78. Roche Recent Developments
    Table 79. UCB (Union Chimique Belge) Company Details
    Table 80. UCB (Union Chimique Belge) Business Overview
    Table 81. UCB (Union Chimique Belge) Novel Drug Delivery Systems Product
    Table 82. UCB (Union Chimique Belge) Revenue in Novel Drug Delivery Systems Business (2017-2022) & (US$ Million)
    Table 83. UCB (Union Chimique Belge) Recent Developments
    Table 84. Celgene Company Details
    Table 85. Celgene Business Overview
    Table 86. Celgene Novel Drug Delivery Systems Product
    Table 87. Celgene Revenue in Novel Drug Delivery Systems Business (2017-2022) & (US$ Million)
    Table 88. Celgene Recent Developments
    Table 89. Merck Company Details
    Table 90. Merck Business Overview
    Table 91. Merck Novel Drug Delivery Systems Product
    Table 92. Merck Revenue in Novel Drug Delivery Systems Business (2017-2022) & (US$ Million)
    Table 93. Merck Recent Developments
    Table 94. Gilead Sciences Company Details
    Table 95. Gilead Sciences Business Overview
    Table 96. Gilead Sciences Novel Drug Delivery Systems Product
    Table 97. Gilead Sciences Revenue in Novel Drug Delivery Systems Business (2017-2022) & (US$ Million)
    Table 98. Gilead Sciences Recent Developments
    Table 99. Sanofi Company Details
    Table 100. Sanofi Business Overview
    Table 101. Sanofi Novel Drug Delivery Systems Product
    Table 102. Sanofi Revenue in Novel Drug Delivery Systems Business (2017-2022) & (US$ Million)
    Table 103. Sanofi Recent Developments
    Table 104. Pfizer Company Details
    Table 105. Pfizer Business Overview
    Table 106. Pfizer Novel Drug Delivery Systems Product
    Table 107. Pfizer Revenue in Novel Drug Delivery Systems Business (2017-2022) & (US$ Million)
    Table 108. Pfizer Recent Developments
    Table 109. Takeda Company Details
    Table 110. Takeda Business Overview
    Table 111. Takeda Novel Drug Delivery Systems Product
    Table 112. Takeda Revenue in Novel Drug Delivery Systems Business (2017-2022) & (US$ Million)
    Table 113. Takeda Recent Developments
    Table 114. Bausch&Lomb Company Details
    Table 115. Bausch&Lomb Business Overview
    Table 116. Bausch&Lomb Novel Drug Delivery Systems Product
    Table 117. Bausch&Lomb Revenue in Novel Drug Delivery Systems Business (2017-2022) & (US$ Million)
    Table 118. Bausch&Lomb Recent Developments
    Table 119. Samyang Biopharmaceuticals Company Details
    Table 120. Samyang Biopharmaceuticals Business Overview
    Table 121. Samyang Biopharmaceuticals Novel Drug Delivery Systems Product
    Table 122. Samyang Biopharmaceuticals Revenue in Novel Drug Delivery Systems Business (2017-2022) & (US$ Million)
    Table 123. Samyang Biopharmaceuticals Recent Developments
    Table 124. Johnson & Johnson Company Details
    Table 125. Johnson & Johnson Business Overview
    Table 126. Johnson & Johnson Novel Drug Delivery Systems Product
    Table 127. Johnson & Johnson Revenue in Novel Drug Delivery Systems Business (2017-2022) & (US$ Million)
    Table 128. Johnson & Johnson Recent Developments
    Table 129. TOLMAR Company Details
    Table 130. TOLMAR Business Overview
    Table 131. TOLMAR Novel Drug Delivery Systems Product
    Table 132. TOLMAR Revenue in Novel Drug Delivery Systems Business (2017-2022) & (US$ Million)
    Table 133. TOLMAR Recent Developments
    Table 134. Astellas Company Details
    Table 135. Astellas Business Overview
    Table 136. Astellas Novel Drug Delivery Systems Product
    Table 137. Astellas Revenue in Novel Drug Delivery Systems Business (2017-2022) & (US$ Million)
    Table 138. Astellas Recent Developments
    Table 139. AMAG Pharmaceuticals Company Details
    Table 140. AMAG Pharmaceuticals Business Overview
    Table 141. AMAG Pharmaceuticals Novel Drug Delivery Systems Product
    Table 142. AMAG Pharmaceuticals Revenue in Novel Drug Delivery Systems Business (2017-2022) & (US$ Million)
    Table 143. AMAG Pharmaceuticals Recent Developments
    Table 144. AbbVie Company Details
    Table 145. AbbVie Business Overview
    Table 146. AbbVie Novel Drug Delivery Systems Product
    Table 147. AbbVie Revenue in Novel Drug Delivery Systems Business (2017-2022) & (US$ Million)
    Table 148. AbbVie Recent Developments
    Table 149. Dr Reddy Company Details
    Table 150. Dr Reddy Business Overview
    Table 151. Dr Reddy Novel Drug Delivery Systems Product
    Table 152. Dr Reddy Revenue in Novel Drug Delivery Systems Business (2017-2022) & (US$ Million)
    Table 153. Dr Reddy Recent Developments
    Table 154. AstraZeneca Company Details
    Table 155. AstraZeneca Business Overview
    Table 156. AstraZeneca Novel Drug Delivery Systems Product
    Table 157. AstraZeneca Revenue in Novel Drug Delivery Systems Business (2017-2022) & (US$ Million)
    Table 158. AstraZeneca Recent Developments
    Table 159. Aspen Company Details
    Table 160. Aspen Business Overview
    Table 161. Aspen Novel Drug Delivery Systems Product
    Table 162. Aspen Revenue in Novel Drug Delivery Systems Business (2017-2022) & (US$ Million)
    Table 163. Aspen Recent Developments
    Table 164. Acrotech Biopharma Company Details
    Table 165. Acrotech Biopharma Business Overview
    Table 166. Acrotech Biopharma Novel Drug Delivery Systems Product
    Table 167. Acrotech Biopharma Revenue in Novel Drug Delivery Systems Business (2017-2022) & (US$ Million)
    Table 168. Acrotech Biopharma Recent Developments
    Table 169. TWi Pharmaceuticals Company Details
    Table 170. TWi Pharmaceuticals Business Overview
    Table 171. TWi Pharmaceuticals Novel Drug Delivery Systems Product
    Table 172. TWi Pharmaceuticals Revenue in Novel Drug Delivery Systems Business (2017-2022) & (US$ Million)
    Table 173. TWi Pharmaceuticals Recent Developments
    Table 174. Research Programs/Design for This Report
    Table 175. Key Data Information from Secondary Sources
    Table 176. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Novel Drug Delivery Systems Market Share by Type: 2021 VS 2028
    Figure 2. Liposomes Features
    Figure 3. PEGylated Proteins & Polypeptides Features
    Figure 4. Polymer Nanoparticle Features
    Figure 5. Protein–drug Conjugates Features
    Figure 6. Others Features
    Figure 7. Global Novel Drug Delivery Systems Market Share by Application: 2021 VS 2028
    Figure 8. Hospitals & Clinic Case Studies
    Figure 9. Cancer Treatment Centers Case Studies
    Figure 10. Others Case Studies
    Figure 11. Novel Drug Delivery Systems Report Years Considered
    Figure 12. Global Novel Drug Delivery Systems Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 13. Global Novel Drug Delivery Systems Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Novel Drug Delivery Systems Market Share by Region: 2021 VS 2028
    Figure 15. Global Novel Drug Delivery Systems Market Share by Players in 2021
    Figure 16. Global Top Novel Drug Delivery Systems Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Novel Drug Delivery Systems as of 2021)
    Figure 17. The Top 10 and 5 Players Market Share by Novel Drug Delivery Systems Revenue in 2021
    Figure 18. North America Novel Drug Delivery Systems Market Size YoY (2017-2028) & (US$ Million)
    Figure 19. North America Novel Drug Delivery Systems Market Size Market Share by Type (2017-2028)
    Figure 20. North America Novel Drug Delivery Systems Market Size Market Share by Application (2017-2028)
    Figure 21. North America Novel Drug Delivery Systems Market Size Share by Country (2017-2028)
    Figure 22. United States Novel Drug Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Canada Novel Drug Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Europe Novel Drug Delivery Systems Market Size YoY (2017-2028) & (US$ Million)
    Figure 25. Europe Novel Drug Delivery Systems Market Size Market Share by Type (2017-2028)
    Figure 26. Europe Novel Drug Delivery Systems Market Size Market Share by Application (2017-2028)
    Figure 27. Europe Novel Drug Delivery Systems Market Size Share by Country (2017-2028)
    Figure 28. Germany Novel Drug Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. France Novel Drug Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. U.K. Novel Drug Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Italy Novel Drug Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Russia Novel Drug Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Nordic Countries Novel Drug Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Asia-Pacific Novel Drug Delivery Systems Market Size YoY (2017-2028) & (US$ Million)
    Figure 35. Asia Pacific Novel Drug Delivery Systems Market Size Market Share by Type (2017-2028)
    Figure 36. Asia Pacific Novel Drug Delivery Systems Market Size Market Share by Application (2017-2028)
    Figure 37. Asia Pacific Novel Drug Delivery Systems Market Size Share by Region (2017-2028)
    Figure 38. China Novel Drug Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Japan Novel Drug Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. South Korea Novel Drug Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Southeast Asia Novel Drug Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. India Novel Drug Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Australia Novel Drug Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Latin America Novel Drug Delivery Systems Market Size YoY (2017-2028) & (US$ Million)
    Figure 45. Latin America Novel Drug Delivery Systems Market Size Market Share by Type (2017-2028)
    Figure 46. Latin America Novel Drug Delivery Systems Market Size Market Share by Application (2017-2028)
    Figure 47. Latin America Novel Drug Delivery Systems Market Size Share by Country (2017-2028)
    Figure 48. Mexico Novel Drug Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Brazil Novel Drug Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 50. Middle East & Africa Novel Drug Delivery Systems Market Size YoY (2017-2028) & (US$ Million)
    Figure 51. Middle East and Africa Novel Drug Delivery Systems Market Size Market Share by Type (2017-2028)
    Figure 52. Middle East and Africa Novel Drug Delivery Systems Market Size Market Share by Application (2017-2028)
    Figure 53. Middle East and Africa Novel Drug Delivery Systems Market Size Share by Country (2017-2028)
    Figure 54. Turkey Novel Drug Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. Saudi Arabia Novel Drug Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. UAE Novel Drug Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 57. Amgen Revenue Growth Rate in Novel Drug Delivery Systems Business (2017-2022)
    Figure 58. Teva Revenue Growth Rate in Novel Drug Delivery Systems Business (2017-2022)
    Figure 59. Roche Revenue Growth Rate in Novel Drug Delivery Systems Business (2017-2022)
    Figure 60. UCB (Union Chimique Belge) Revenue Growth Rate in Novel Drug Delivery Systems Business (2017-2022)
    Figure 61. Celgene Revenue Growth Rate in Novel Drug Delivery Systems Business (2017-2022)
    Figure 62. Merck Revenue Growth Rate in Novel Drug Delivery Systems Business (2017-2022)
    Figure 63. Gilead Sciences Revenue Growth Rate in Novel Drug Delivery Systems Business (2017-2022)
    Figure 64. Sanofi Revenue Growth Rate in Novel Drug Delivery Systems Business (2017-2022)
    Figure 65. Pfizer Revenue Growth Rate in Novel Drug Delivery Systems Business (2017-2022)
    Figure 66. Takeda Revenue Growth Rate in Novel Drug Delivery Systems Business (2017-2022)
    Figure 67. Bausch&Lomb Revenue Growth Rate in Novel Drug Delivery Systems Business (2017-2022)
    Figure 68. Samyang Biopharmaceuticals Revenue Growth Rate in Novel Drug Delivery Systems Business (2017-2022)
    Figure 69. Johnson & Johnson Revenue Growth Rate in Novel Drug Delivery Systems Business (2017-2022)
    Figure 70. TOLMAR Revenue Growth Rate in Novel Drug Delivery Systems Business (2017-2022)
    Figure 71. Astellas Revenue Growth Rate in Novel Drug Delivery Systems Business (2017-2022)
    Figure 72. AMAG Pharmaceuticals Revenue Growth Rate in Novel Drug Delivery Systems Business (2017-2022)
    Figure 73. AbbVie Revenue Growth Rate in Novel Drug Delivery Systems Business (2017-2022)
    Figure 74. Dr Reddy Revenue Growth Rate in Novel Drug Delivery Systems Business (2017-2022)
    Figure 75. AstraZeneca Revenue Growth Rate in Novel Drug Delivery Systems Business (2017-2022)
    Figure 76. Aspen Revenue Growth Rate in Novel Drug Delivery Systems Business (2017-2022)
    Figure 77. Acrotech Biopharma Revenue Growth Rate in Novel Drug Delivery Systems Business (2017-2022)
    Figure 78. TWi Pharmaceuticals Revenue Growth Rate in Novel Drug Delivery Systems Business (2017-2022)
    Figure 79. Bottom-up and Top-down Approaches for This Report
    Figure 80. Data Triangulation
    Figure 81. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Amgen
Teva
Roche
UCB (Union Chimique Belge)
Celgene
Merck
Gilead Sciences
Sanofi
Pfizer
Takeda
Bausch&Lomb
Samyang Biopharmaceuticals
Johnson & Johnson
TOLMAR
Astellas
AMAG Pharmaceuticals
AbbVie
Dr Reddy
AstraZeneca
Aspen
Acrotech Biopharma
TWi Pharmaceuticals
Frequently Asked Questions
Novel Drug Delivery Systems report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Novel Drug Delivery Systems report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Novel Drug Delivery Systems report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Motorcycle Gear

Motorcycle Gear market is segmented by Type and by Application. Players, stakeholders, and other  ... Read More